Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery. 2011

Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
Department of Cardiovascular Surgery, Nicosia State Hospital, Nalbantoglu Lefkosa Devlet Hastanesi, Ortakoy, Nicosia, Cyprus. ozanemiroglu@gmail.com

BACKGROUND Emerging perioperative genomics may influence the direction of risk assessment and surgical strategies in cardiac surgery. The aim of this study was to investigate whether single nucleotide polymorphisms (SNP) affect the clinical presentation and predispose to increased risk for postoperative adverse events in patients undergoing coronary artery bypass grafting surgery (CABG). METHODS A total of 220 patients undergoing first-time CABG between January 2005 and May 2008 were screened for factor V gene G1691A (FVL), prothrombin/factor II G20210A (PT G20210A), angiotensin I-converting enzyme insertion/deletion (ACE-ins/del) polymorphisms by PCR and Real Time PCR. End points were defined as death, myocardial infarction, stroke, postoperative bleeding, respiratory and renal insufficiency and event-free survival. Patients were compared to assess for any independent association between genotypes for thrombosis and postoperative phenotypes. RESULTS Among 220 patients, the prevalence of the heterozygous FVL mutation was 10.9% (n = 24), and 3.6% (n = 8) were heterozygous carriers of the PT G20210A mutation. Genotype distribution of ACE-ins/del was 16.6%, 51.9%, and 31.5% in genotypes I/I, I/D, and D/D, respectively. FVL and PT G20210A mutations were associated with higher prevalence of totally occluded coronary arteries (p < 0.001). Furthermore the risk of left ventricular aneurysm formation was significantly higher in FVL heterozygote group compared to FVL G1691G (p = 0.002). ACE D/D genotype was associated with hypertension (p = 0.004), peripheral vascular disease (p = 0.006), and previous myocardial infarction (p = 0.007). CONCLUSIONS FVL and PT G20210A genotypes had a higher prevalence of totally occluded vessels potentially as a result of atherothrombotic events. However, none of the genotypes investigated were independently associated with mortality.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D005260 Female Females

Related Publications

Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
January 2005, International journal of cardiology,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
August 2015, Scientific reports,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
March 2007, International journal of cardiology,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
June 2022, General thoracic and cardiovascular surgery,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
January 2015, Circulation journal : official journal of the Japanese Circulation Society,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
December 2011, Journal of cardiothoracic and vascular anesthesia,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
December 1996, Chest,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
January 2001, Circulation,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
February 2002, Anesthesia and analgesia,
Ozan Emiroglu, and Serkan Durdu, and Yonca Egin, and Ahmet R Akar, and Yesim D Alakoc, and Cagin Zaim, and Umit Ozyurda, and Nejat Akar
April 2008, Indian pacing and electrophysiology journal,
Copied contents to your clipboard!